the massive trade and managed to trade millions on the market.According to the records, the volume jump is most probably in connection with the last news by Positron Corporation. Last week, it was reported the company was going to launch its automated radiopharmaceutical system at the two upcoming industry conferences in March and April this year.
This news gave new hopes not only to POSC, but also to investors in a hurry to secure some of the company’s shares. Yet, the results of the conferences are early to be revealed.
Positron Corporation is a molecular imaging company focused on Nuclear Cardiology. Last year, the company used to trade significantly higher than now, though since May the stock price has become about six times lower. While in the meantime, POSC has been struggling to pump it up with positive press releases. How long will the current up move survive this time is still a mystery.[BANNER]
According to its latest annual report, the revenues of Positron have decreased due to the continuous decline of sales and terminated contracts. Besides, the company’s operating expenses reached over $4 million for a year and the net loss struck $0.02 per share.
Due to the shocking accumulated deficit since inception accompanied by huge liabilities, the continuation of Positron Corp. has been placed under a substantial doubt. It means that if the company is unable to obtain debt or equity financing, it may have to severely limit or cease its business activities.
